Literature DB >> 1054156

Methoxy-9-ellipticine lactate in refractory acute myeloid leukaemia.

B M Ansari, E N Thompson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1054156      PMCID： PMC2495705          DOI： 10.1136/pgmj.51.592.103

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  4 in total

1.  Refractory leukemia treated with cytosine arabinoside and cyclophosphamide.

Authors:  B M Ansari; E N Thompson
Journal:  Cancer       Date:  1973-08       Impact factor: 6.860

2.  Methoxy-9-ellipticine. II. Analysis in vitro of the mechanism of action.

Authors:  E Garcia-Giralt; A Macieira-Coelho
Journal:  Rev Eur Etud Clin Biol       Date:  1970-05

3.  Methoxy-9-ellipticine lactate. 3. Clinical screening: its action in acute myeloblastic leukaemia.

Authors:  G Mathé; M Hayat; F De Vassal; L Schwarzenberg; M Schneider; J R Schlumberger; C Jasmin; C Rosenfeld
Journal:  Rev Eur Etud Clin Biol       Date:  1970-05

4.  Combination chemotherapy using L-asparaginase, daunorubicin, and cytosine arabinoside in adults with acute myelogenous leukaemia.

Authors:  D Crowther; C J Bateman; C P Vartan; J M Whitehouse; J S Malpas; G H Fairley; R B Scott
Journal:  Br Med J       Date:  1970-11-28
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.